Cargando…
Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine
Epstein–Barr virus (EBV), a member of the Herpesviridae family, maintains a lifelong latent infection in human B cells. Switching from the latent to the lytic phase of its lifecycle allows the virus to replicate and spread. The viral lytic cycle is induced in infected cultured cells by drugs such as...
Autores principales: | Anderson, Abbie G., Gaffy, Cullen B., Weseli, Joshua R., Gorres, Kelly L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563273/ https://www.ncbi.nlm.nih.gov/pubmed/31108875 http://dx.doi.org/10.3390/v11050450 |
Ejemplares similares
-
Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus
por: Gorres, Kelly L., et al.
Publicado: (2016) -
Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation
por: Murata, Takayuki, et al.
Publicado: (2021) -
Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis
por: Li, Hongde, et al.
Publicado: (2016) -
Leukopenia and agranulocytosis in atypical antipsychotic treatment - besides clozapine
por: Jorge, B., et al.
Publicado: (2021) -
PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter
por: Lupey-Green, Lena N., et al.
Publicado: (2017)